Benchmark International is pleased to announce the transaction between Kent-based Maitland Medical and London-based The Doctors Clinic Group (DCG).
Established in 1995, Maitland Medical is an occupational health advisory/consultancy, supporting businesses with recruitment, the promotion of wellbeing at work and absence management. It has a strong team of occupational health specialists delivering tailored, high quality clinical advice and support for corporate clients, SMEs, schools and academies.
DCG provides a comprehensive range of affordable GP services, including consultations, health screens, blood tests, diagnostics and some common secondary care pathways, from 15 locations throughout London. It provides affordable and easy access for individuals, corporates and insurers to private GPs.
The acquisition is part of a strategy to become a national healthcare services platform in the UK, allowing both companies to extend their geographical reach and allow DCG to offer additional services such as absence management and ‘fitness for task’ medicals.
Julie Michalski, Managing Director of Maitland Medical, said: “Our entire team at Maitland and our new colleagues are excited to share strongly aligned values and begin to focus on the additions we can make to all of the services we offer.”
James Robinson, Associate Director at Benchmark International, commented: “We are delighted for our clients John and Julie as we achieved not only the deal they wanted, but to an ambitious acquirer who holds the same business ethos and no doubt will take Maitland Medical Service to new heights. It was a pleasure working with our client and we wish them every success for the future.”
DCG is backed by private equity company, Oakfield Capital Partners, an investor in UK companies that partners with management teams to provide capital and expertise.
WE ARE READY WHEN YOU ARE
Call Benchmark International today if you are interested in an exit or growth strategy or if you are interested in acquiring.
Categories
Get These Insights Delivered Directly To Your Email
Explore our curated collection today and stay ahead of the curve in M&A.